Identification
A:
Examine the chromatograms obtained in the test for Chromatographic purity:the principal spot obtained from the Test solutionis similar in RFvalue,color,and intensity to that obtained from the Standard stock solution.
B:
The retention time exhibited by pindolol in the chromatogram of the
Assay preparationcorresponds to that of pindolol in the chromatogram of the
Standard preparation,as obtained in the
Assay.
Dissolution,Procedure for a Pooled Sample á711ñ
Medium:
0.1Nhydrochloric acid;500mL.
Apparatus 2:
50rpm.
Time:
15minutes.
Mobile phase
and
Chromatographic systemProceed as directed in the
Assay.
Standard solution
Dissolve an accurately weighed quantity of
USP Pindolol RSin
Dissolution Mediumto obtain a solution having a known concentration of about 0.002
Jmg per mL,
Jbeing the labeled quantity,in mg,of pindolol in each Tablet.Mix equal volumes of this solution and of
Mobile phaseto obtain the
Standard solution.
Resolution solution
Dissolve a quantity of nortriptyline hydrochloride in Standard solutionto obtain a solution having a concentration of about 0.005mg of nortriptyline hydrochloride per mL.
Test solution
Filter a portion of the solution under test.Mix equal volumes of the filtrate and of Mobile phaseto obtain the Test solution.
Procedure
Proceed as directed for
Procedureunder the
Assay.Calculate the quantity of C
14H
20N
2O
2dissolved by the formula:
500C(rU/rS),
in which
Cis the concentration,in mg per mL,of
USP Pindolol RSin the
Standard solution;and
rUand
rSare the pindolol peak responses obtained from the
Test solutionand the
Standard solution,respectively.
Tolerances
Not less than 80%(Q)of the labeled amount of C14H20N2O2is dissolved in 15minutes.
Chromatographic purity
[NOTEProtect solutions and chromatographic plate (after application of solutions)from light.
]
p-Dimethylaminobenzaldehyde spray
Dissolve 1g of p-dimethylaminobenzaldehyde in a mixture of 50mLof hydrochloric acid and 50mLof alcohol,and mix.[NOTEStore this solution in a tightly closed,light-resistant container,and discard after 4weeks.]
Solvent mixture
Prepare a solution of methanol and glacial acetic acid (99:1).
Standard stock solution
Dissolve an accurately weighed quantity of
USP Pindolol RSin
Solvent mixtureto obtain a solution containing 5.0mg per mL.
Standard solution 1
Dilute an accurately measured volume of Standard stock solutionquantitatively and stepwise with Solvent mixtureto obtain a solution containing 0.025mg per mL.
Standard solution 2
Dilute 6.0mLof Standard solution 1with Solvent mixtureto 10.0mL,and mix.
Standard solution 3
Dilute 4.0mLof Standard solution 1with Solvent mixtureto 10.0mL,and mix.
Standard solution 4
Dilute 2.0mLof Standard solution 1with Solvent mixtureto 10.0mL,and mix.
Test solution
[NOTEPrepare this solution immediately before use,and apply last.]Transfer a portion of powdered Tablets,equivalent to 50mg of pindolol,to a 50-mLflask,add 10.0mLof Solvent mixture,insert the stopper in the flask,and shake by mechanical means for 15minutes.Centrifuge a portion of the resultant suspension,and promptly test the clear supernatant.
Procedure
Prepare a lined chromatographic chamber (see
Chromatography á621ñ)with a developing solvent consisting of a mixture of methylene chloride,methanol,and formic acid (75:23.5:1.5),and equilibrate for 30minutes.Separately apply 2-µLportions of the
Standard stock solution,each of the
Standard solutions,and the
Test solutionto a thin-layer chromatographic plate coated with a 0.25-mm layer of chromatographic silica gel.Place the plate in the chromatographic chamber,and allow the solvent front to move about two-thirds of the length of the plate.Remove the plate from the chamber,immediately spray with the
p-
Dimethylaminobenzaldehyde spray,heat the plate at 60

for 15minutes,and promptly examine the chromatogram:no individual secondary spot observed in the chromatogram of the
Test solutionis greater in size or intensity than the principal spot observed in the chromatogram of
Standard solution 1,corresponding to 0.5%,and the total of any such spots observed does not exceed 3.0%.
[NOTEIn a valid determination,spots from all solutions must be visible.
]
Assay
Ammonium carbonate solution
Dissolve 300mg of ammonium carbonate in 50mLof water,and mix.
Mobile phase
Prepare a filtered and degassed mixture of acetonitrile,methanol,and
Ammonium carbonate solution(475:475:50),making adjustments,if necessary (see
System Suitabilityunder
Chromatography á621ñ).
Standard preparation
Prepare a solution of
USP Pindolol RSin
Mobile phaseto obtain a solution having a known concentration of about 0.2mg per mL.
Resolution solution
Dissolve a quantity of nortriptyline hydrochloride in Standard preparationto obtain a solution having a concentration of about 0.2mg of nortriptyline hydrochloride per mL.
Assay preparation
Weigh and finely powder not less than 20Tablets.Transfer an accurately weighed portion of the powder,equivalent to about 20mg of pindolol,to a 100-mLvolumetric flask.Add 4mLof water,and sonicate for 2minutes,with occasional shaking to disperse the powder.Add 30mLof Mobile phase,sonicate for 15minutes,and allow to cool.Dilute with Mobile phaseto volume,mix,and filter.Use the clear filtrate as the Assay preparation.
Chromatographic system (see Chromatography á621ñ)
The liquid chromatograph is equipped with a 254-nm detector and a 4.6-mm ×25-cm column that contains packing L16.The flow rate is about 3mLper minute.Chromatograph the
Resolution solution,and record the peak responses as directed for
Procedure:the resolution between pindolol and nortriptyline is not less than 1.5.Chromatograph the
Standard preparation,and record the peak responses as directed for
Procedure:the relative standard deviation for replicate injections is not more than 2.0%.
Procedure
Separately inject equal volumes (about 10µL)of the
Standard preparationand the
Assay preparationinto the chromatograph,record the chromatograms,and measure the responses for the major peaks.The relative retention times are about 0.6for pindolol and 1.0for nortriptyline.Calculate the quantity,in mg,of pindolol (C
14H
20N
2O
2)in the portion of Tablets taken by the formula:
100C(rU/rS),
in which
Cis the concentration,in mg per mL,of
USP Pindolol RSin the
Standard preparation;and
rUand
rSare the pindolol peak responses obtained from the
Assay preparationand the
Standard preparation,respectively.